5 pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
The mark consists of myosin heads going moving in a swirling motion. Color is not claimed as a feature of the mark.